Literature DB >> 1588320

Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells.

J M Katz1, R G Webster.   

Abstract

Primary isolation of type A influenza (H3N2) virus in mammalian Madin Darby canine kidney (MDCK) cells results in a virus with haemagglutinin (HA) identical to that of the virus replicating in the infected individual, whereas similar isolation of virus in the embryonated egg results in the selection of variants with amino acid substitutions in the globular head region of the HA molecule. To determine whether other mammalian and avian host cells routinely used in laboratory isolation of influenza viruses also impose a selective pressure on the replicating virus population, the HA of viruses isolated in several different primary or continuous mammalian cells or avian cells has been characterized. The HAs of H3N2 viruses isolated in monkey kidney LLC-MK2 and primary guinea-pig kidney cell culture were antigenically identical to MDCK cell-grown virus isolated from the same patient. The deduced amino acid sequence over the region of HA1 encoding residues implicated in host cell-mediated sequence variation revealed that the HA sequences of viruses isolated and passaged in these mammalian cell types, and in a human lung continuous cell line (MRC-5), were identical to that of the virus present in the infected individual. In addition, isolation of virus in avian primary chick kidney (CK) cells yielded a predominant virus with HA identical to that of mammalian cell-grown virus and the virus present in the original clinical material. However, passage of CK cell-grown virus in chicken embryos (eggs) resulted in the predominance of viruses with amino acid substitutions in HA, a minority of which resulted in antigenic variation. Since CK cell culture is used in the development of live attenuated influenza vaccines, the sequence identity between CK cell-grown virus and the virus present in the infected individual is reassuring. Nevertheless, subsequent passage of virus strains in eggs, necessary for vaccine production, must be monitored closely.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588320     DOI: 10.1099/0022-1317-73-5-1159

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion.

Authors:  Shin Murakami; Taisuke Horimoto; Mutsumi Ito; Ryo Takano; Hiroaki Katsura; Masayuki Shimojima; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

2.  Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein.

Authors:  M R Castrucci; Y Kawaoka
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

3.  Genetic and antigenic variation in the haemagglutinin of recently circulating human influenza A (H3N2) viruses in the United Kingdom.

Authors:  J S Ellis; P Chakraverty; J P Clewley
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.

Authors:  I V Alymova; S Kodihalli; E A Govorkova; B Fanget; C Gerdil; R G Webster
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 5.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.

Authors:  E A Govorkova; G Murti; B Meignier; C de Taisne; R G Webster
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection.

Authors:  T Ito; Y Suzuki; A Takada; A Kawamoto; K Otsuki; H Masuda; M Yamada; T Suzuki; H Kida; Y Kawaoka
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus.

Authors:  M L Herlocher; H F Maassab; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells.

Authors:  Shin Murakami; Taisuke Horimoto; Le Quynh Mai; Chairul A Nidom; Hualan Chen; Yukiko Muramoto; Shinya Yamada; Ayaka Iwasa; Kiyoko Iwatsuki-Horimoto; Masayuki Shimojima; Akira Iwata; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

Review 10.  Cell-based influenza vaccines: progress to date.

Authors:  Jennifer M Audsley; Gregory A Tannock
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.